Thyroid Function and Sarcopenia: Results from the ELSA-Brasil Study.

Autor: Szlejf C; Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, Brazil., Suemoto CK; Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, Brazil.; Division of Geriatrics, University of São Paulo Medical School, São Paulo, Brazil., Janovsky CCPS; Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, Brazil., Barreto SM; Faculty of Medicine, Universidade Federal de Minas Gerais, Minas Gerais, Brazil., Diniz MFHS; Faculty of Medicine, Universidade Federal de Minas Gerais, Minas Gerais, Brazil., Lotufo PA; Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, Brazil.; Department of Internal Medicine, University of São Paulo Medical School, São Paulo, Brazil., Bensenor IM; Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, Brazil.; Department of Internal Medicine, University of São Paulo Medical School, São Paulo, Brazil.
Jazyk: angličtina
Zdroj: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2020 Jul; Vol. 68 (7), pp. 1545-1553. Date of Electronic Publication: 2020 Mar 13.
DOI: 10.1111/jgs.16416
Abstrakt: Objectives: We aimed to investigate the association of subclinical thyroid disease and thyroid hormone levels with sarcopenia and its defining components in community-dwelling middle-aged and older adults without overt thyroid dysfunction.
Design: Cross-sectional study.
Setting: Active and retired employees from public institutions located in six Brazilian cities.
Participants: A total of 6974 participants from the ELSA-Brasil study's second wave, aged 50 years and older, without overt thyroid dysfunction and with complete data for exposure, outcome, and covariates.
Methods: Serum levels of thyrotropin (TSH), free thyroxine, and free triiodothyronine (FT3) were measured and divided in quintiles for the analyses. Participants were classified with euthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism. Muscle mass was assessed by bioelectrical impedance analysis and muscle strength by handgrip strength. Sarcopenia was defined according to the Foundation for the National Institutes of Health criteria. Possible confounders included sociodemographic characteristics, clinical conditions, and lifestyle. Analyses were performed separately for middle-aged and older adults (≥65 y).
Results: The frequencies of sarcopenia, low muscle mass, low muscle strength, subclinical hypothyroidism, and subclinical hyperthyroidism were 1.5%, 20.8%, 3.8%, 9.1%, and .9%, respectively. Subclinical thyroid dysfunction was not associated with sarcopenia and its defining components. Among older adults, TSH had a U-shaped association with sarcopenia and low muscle strength. The odds ratios (ORs) (95% confidence intervals [CIs]) for the associations of the first, second, fourth, and fifth quintile with sarcopenia, respectively, were 5.18 (1.47-18.28), 6.28 (1.82-21.73), 4.12 (1.15-14.76), and 4.81 (1.35-17.10), and with low muscle strength was (OR (95% CI) for the first, second, and fifth quintiles, respectively: 1.43 (1.16-5.07), 2.07 (1.24-4.70), and 2.18 (1.03-4.60). Additionally, FT3 had a negative association with muscle mass in both age strata.
Conclusion: Subtle thyroid hormone alterations are associated with sarcopenia or its defining components in middle-aged and older adults without overt thyroid dysfunction. J Am Geriatr Soc 68:1545-1553, 2020.
(© 2020 The American Geriatrics Society.)
Databáze: MEDLINE
Externí odkaz: